1 - 日本人間ドック学会
Contents
1. C RAD 5 72. 107 0052 9 6 41 TEL 03 3475 5618 FAX 03 3475 5619 E mail info jaacc jp Notice about photocopying In order to photocopy any work from this publication you or your organization must obtain permission from the following organization which has been delegated for copyright clearance by the copyright owner of this publication Japan Academic Aasociation for Copyright Clearance Inc JAACC
3. IT
4. 1 2 3 4 5 6 7 8 Vol 29 No 3 2014 51 509 xt AVEO SOL
5. 68 34 82 59 1 T I IL 4 2 5 8 p 0 mL JEBE 8 7U mL p 0 015 023 42 2U
6. m 54 2013 8 29 X B 1 2010 24 1060 1066 2 1997 35 809 813 3 2009 24 352 4
7. Ek 2 TOR 3 Microsoft Word doc docx xls xlsx ppt pptx jpg tiff gif ai eps psd honbun doc zul jpg hyoul xls E
8. AS BR TM 24 4 1 25 3 31 25 352 25 352 4 772 4 697 136 129 86 64 48 258 13 79 15 15111 38 18 17
9. E 2015 7 30 A 31 BH SE Bs T 220 0012 1 1 1 Tel 045 221 2155 http www pacifico co jp http convention jtbcom co jp 56jsnd Be E i T 252 0206 3 2 8 JTB T 141 8657 2 24 9 3F Tel 03 5434 8759 Fax 050 3730 3977 FAX E mail 56jsnd jtbcom
10. Vol 29 No 3 2014 2011 24 6 2012 26 9
11. 2009 15mg dL 1 1 1 0 1 5L 150 225mg 30 300mg H H 36 494
12. 2 kot Vol 29 No 3 2014 PCR RE RB
13. A4 MS 12 40 x20 CD ROM d 2 CD ROM OS Windows Macintosh K 6 12 000 4 8000 8 16 000 Letters to the Editor 8 1 200
14. S L i25
15. 2011 14 472 2012 X X 2010
16. 23 OFF 5 3 2 133 2 3 86 3 83 25 5 3 2 131 2 4 107 1 2 81 o5 Vol 29 No 3 2014 1 1 2 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 1 2 3 4 1 2
17. 9 10 12 11 13 DVD TH 15 22 24 HE e learning FIC DBS
18. a T d p lt 0 05 j 60 60 40 40 x 20 20 0 0 stagell stagell stagel II SEH stagell stagell stagel 13 27 33 51 6 17 13 25 30 78 41 95 47 125 93 219 20 38 35 65 1 5 10 24 48 65 35 52 38 4390 3896 42 53 54 20 42 BR E 26 3 454 466 2011 1 15 8
19. 26 P A tk 2 EO d o E a B M I E W 2 ats ho WE d E E dE 7 R d E 7 R od EE Uy HE HE BEE 1 1 1 X i x d 2 X 4 8 m EA ES ik K X HDL LDL Friedewald OW AST GOT ALT GPT y GT y GTP A L P HbA1c Do X A t Wy
20. Hb Dill 2 5 2011
21. P Lu 22 480 Vol 29 No 3 2014 1
22. WIET ARER REAR Ae 76 34 186 72 87 159 33 BOL 3 OR 1 25 QE 2 25
23. C ERLT RI ZFA amp un fug 6378 9 AICS 4 0 5 EDTA 2Na 6432 7 AICS 5 138 05 EDTA 2Na x x x 6433 4 AICS 2 NN AICS AICS 4 AICS 5 AICS 2
24. 47 2 EH 64 522 Vol 29 No 3 2014 26 6 19 LERA 2 ON HEREA REME AH e ERR AC PA ras A BI ES aa AK f eT T pis 3 Ms z T f me A D DUM oy f uessa MH EI e veis id Sia Vol 29 No 3 2014 65 523 n a Ti 2
25. HbA1c NGSP ea X B Index Medicus 2 CD ROM 1 COI
26. 1 SI kg g mg dL L mL m cm TRE 3 1 234 567 890 Dj 1 400 K A4 A4 OS CD ROM Bd K
27. Vol 29 No 3 2014 m 1 RT 1 2 133 LPL 3 3 83 2 3 86 2 2 4 107 1 2 81
28. 5
29. DVD vc bb
30. 3X B ASMR X E BA dau i a PAR E 1 IMS BSR
31. B D N 38 52 6 4 2 B pe ee 83 3 4 4 B BAS
32. Vol 29 No 3 2014 26 6 5 Vol 29 No 3 2014 59 517 26 H 26 6 19 CR 15 00 16 30 8 SEN ARAF ABB GERE PETAT AIC MIRR A Be 88 di R ARL TER ENR de MRE AREE
33. 2 3 2012 2013 2009 2012 2 2011 lt
34. 25 11 13 15 25 1 25 12 4 678 25 12 26 26 1 21 T 1 1 2 14 23 25 TE 640 13 7 3 4
35. 7 2005 2011 6 2005 6 CKD CKD 6 DREAD
36. 76 534 Vol 29 No 3 2014 2 D 2
37. E X B 1 2013 2014 60 82 2 2013 2014 60 194 195 3 I 2013 28 608 615 4
38. 2009 iu gs 029 BAS BEE 029 CT 0209 1 mE 2011 10 24 11 H 15 HT 332 236 96 43 0 23 4 22 0 54 2 19 2 2012
39. 1 H Vol 29 No 3 2014
40. A m 2 OR 5 et 39 10 8 27 28 Ala ERR EGE 40 11 8 26 27 41 12 8 24 25 42 13 8 30 31 43 14 8 29 30 21 44 15 8 28 29 45 16 8 26 27 46 17 8 25 26 47 18 9 14 15 E 48 19 8 30 31
41. 4 2 1 2 3 4 5 6 7 8 9 10 11 MH E E 2010 58 101 103 1 16 12 28 173 31 213 E11 2 22 234 Conflict of Interest COD f 144 12 28 203 14 28
42. 27 6 X 24 2 16 0 14 7 10 8 2011 2012 X X 18 6 11 5 15 1 3 2011 4 4 2012 7 7 16 474 5 20 UU
43. M ML WIBE HET UP E MEAN RERA MRE PEE PETAT MBAR 30 3 SWORE OV CHE 19 4 DM mo pn Vol 29 No 3 2014 61 519 Ae UG KE St 19 fed AT
44. Vol 29 No 3 2014 2
45. I T
46. EDV MASA MEE Be Ua ERZ 9 90 PSHE LVS BRE an gt dental plaque subgingival plaque D
47. SPSS ver17 for Windows 74 532 Vol 29 No 3 2014 4 a 1 2 3 Tel Fax E mail 2AE 600 4 3HH 250 words 4 3
48. Gilbert PASE ee Wa PAE a 1 2 b 1 5 c 2 3 d 3 4 e 4 5 9 1 a 1000Hz 30dB 2000Hz 30dB b 1000Hz 30dB 2000Hz 40dB c 1000Hz 40dB 2000Hz 40dB d 1000Hz 30dB 4000Hz 30dB e 1000Hz 40dB 4000Hz 30dB 10 1 a CT b MRI c d e 11 D 2 3 4 EGFR epidermal growth factor receptor mutation 5 EGFR TKI epiderma
49. 21 2010 11 Abe Y lijima K Ohara S et al A Japanese case series of 12 patients with esophageal eosinophilia J Gastroenterol 2011 46 25 30 12 Rothenberg ME Biology and treatment of eosinophilic esophagitis Gastroenterology 2009 137 1238 1249 13 Kinoshita Y Furuta K Ishimaura N et al Clinical characteristics of Japanese patients with eosinophilic esophagitis and eosinophilic gastroenteritis J Gastroenterol 2013 48 333 339 M ller S P hl S Vieth M et al Analysis of symptoms and endoscopic findings in 117 patients with histological diagnoses of eosinophilic esophagitis Endoscopy 2007 39 339 344 Mackenzie SH Go M Chadwick B et al Eosinophilic oesophagitis in patients presenting with dysphagia a prospective analysis Aliment Pharmacol Ther 2008 28 1140 1146 Nielsen JA Lager DJ Lewin M et al The optimal number of biopsy fragments to establish a morphologic diagnosis of eosinophilic esophagitis Am J Gastroenterol 2014 109 515 520 17 Gonsalves N Policarpio Nicolas M Zhang Q et al Histopathologic variability and endoscopic correlates in adults with eosinophilic esophagitis Gastrointest Endosc 200
50. 6 2010 2010 2011 2009 2012 X 24 2 16 0 14 7 10 8 EK SE FH
51. A Er A A A A A A A A A A A A A Vol 29 No 3 2014 83 541 3 COI 1 1 100 1 100 5 1 100 1 50 m
52. 1 ELK TI Cli 5 6
53. 25 352 4 772 18 8 4 697 AAR WRI 129 fF 64 E 180 110mmHg e b Ke PEN ET REZIME 1mm e e e GH 30 40mm RRRA OTIR reu mit e gg IMBBENUE 15mm Eum TH BF e 136 2 9 2 1 O 29 30 39 40 49 50 59 B60 69 870 795 a805 amp 94 TUTUP 145 1 N 4772 0 10 20 30 40 60 70 80 90 100 1 20 478 Vol 29 No 3 2014 86 66 7 2 2 48
54. 1 2005 2011 2 1 B Hk 4 9 9 0 1 7 3 9 gt eGFR 5 1 8 8 4 9 6 3 EXREA Fic 2 12 1 94 2 32 eGFR 1 61 1 79 1 30 1 74 1 86 1 47 1 20 CH
55. 4 E mail E mail E mail The 56th Scientific Meeting of Japan Society of Ningen Dock pes A 1 A 15 A 2 A 16 A 3 A 17 A 4 A 18 RB A 5 A 19 ERK A 6 A 20 REREH A 7 A 21 A 8 A 22 A 9 A 23 A 10 A 24 A 11 Br BB BR Ae A 25 A 12 B kris A 26 A 13 BUER BART A 27 A 14 B B 4 B 7 B 2 B 8
56. A H Vol 29 No 3 2014 54 2013 X B D XX 2011 26 420 2 2012 44 68 69 3 dm 2009 19 98 102 4
57. m ft 3 AHRQCK 2000
58. 2010 24 1236 1242 I 2013 28 241 2012 27 535 546 IU PITE 2012 27 676 681 http www nichibyo co jp m_guidance_01 html 2014 7 14 DVD 56 514 Vol 29 No 3 2014 25 5 H 26 6 5 CR 14 00 15 30 3
59. 1 Vol 29 No 3 2014 2 D 6 2012 6 2011 6
60. Sik 54 MSD D ET 80436477 X dA 1 Marshall BJ Warren JR Unidentified curved bacilli in the stomach of patients with gastritis and peptic ulceration Lancet 1984 1 1311 1315 2 Parsonnet J Friedman GD Vandersteen DP et al Helicobacter pylori infection and the risk of gastric carcinoma N Engl J Med 1991 325 1127 1131 3 Uemura N Okamoto S Yamamoto S et al Helicobacter pylori infection and the development of gastric cancer N Engl J Med 2001 345 784 789 4 Brown LM Helicobacter pylori epidemiology and routes of transmission Epidemiol Rev 2000 22 283 297 5 Umeda M Kobayashi H Takeuchi Y et al High prevalence of Helicobacter pylori detected by PCR in the oral cavities of periodont
61. dE 3 Vol 29 No 3 2014 75 533 6 7 30 100 30 20 20 10 1 100 8 6 4 8 Letters to the Editor 1 10 000 Vete Bl
62. 03 3354 2004 FAX 03 3354 2017 E mail sadoku scientist press com 1 NN BEC SRO LES BIBLE 72 530 Vol 29 No 3 2014 2
63. 24 4 1 25 3 31 25 352 14 275 11 077 47 0 2 25 6 4 6 29 25 8 8
64. 25 31 5 5 108 T
65. 2011 4 1 2012 3 31 8 572 347 308 39 5 A B 2 Ajzen p 0 05 A lt lt gt lt lt gt
66. tk 4 COR 1
67. K SPSS ver17 for Windows 4 a 1 ZILE EZ Tel Fax E mail x 70 528 Vol 29 No 3 2014 2 2AE 600 4 3 3AE 250 words AN 4 SV
68. JMP SAS USA x Student t uU BIBLAIREEO EA e RS CERE 42 2 U mL JEBIE 8 7U mL p 0 015 Cu VARO AARO EIT E 1 RESA BRE p U mL 8 7 42 21 0 015 I WE 5 8 4 21 0 023 Vol 29 No 3 2014 1 II 4 2 5 8 p 0 023 1 L
69. lt CKD HUES 7 REA 6 Dill in ik 2005 2011 7 222 255 B 1 00 0 55 48 6 11 8 2 4 2 eGFR 7 2005 2011 1 00
70. IE 70 29 3 Vol 29 No 3 2014 26 9 30 7102 0075 9 15 1F 03 3265 0079 E mail info ningen dock jp 5 8 10 605 fT B mi Z R mR C MEE ANGE 8 ERE 13376
71. 2010 E I lk FT 6
72. 2004 13 71 74 5 Karen Glanz Barbara K Rimer Frances Marcus Lewis fff 4 2009 77 90 6 4 2002 37 46 7 19 2 1 7 28 http www8 cao go P kourei ishiki h197sonae 43 501 zentai pdf 2 1 pdf 2013 12 10 10 HZ 8 REITE MIE TEE OER 2006 15 411 421 2003 2 11 AHR 1 11 2006 55 191 206 9 BRET
73. BAB 1 834 1 655 74 3 563 6 464 Vol 29 No 3 2014 B 29 465 470 2014 4 d ROMs BAP Key words lifestyle related diseases oxidative related diseases d ROMs test BAP test 1996 8 12
74. 2005 20 347 2014 1 30 2014 5 30 17 475 Efforts to Encourage Health Check up Examinees to Undergo Further Examinations and Their Results Madoka Takeuchi Arisa Kikuchi Tomoko Ishibiki Keiko Mitsuhata Yuri Hiranuma Yukio Ono Takashi Naito TSUKUBA Medical Center Foundation Total Health Evaluation Center Tsukuba Abstract Objective At our facility we are making efforts to raise the percentage of examinees undergoing further examinations focusing on cancer screening Since 2010 we have been studying effective methods of encouraging people to undergo further examinations and have improved working procedures We studied the effectiveness of these methods Methods We made it a necessary requirement to issue referral letters to examinees deemed to need further examination in health check up cancer screening In addition to encouraging examinees to undergo further examinations in interviews with public health nurses in order to provide appropriate information on medical institutions vari ous tools for were made available such as a list of referral medical institutions and tablet computers Furthermore when the further examination status i e undergone or not or their results were not known we conducted a follow up investigation 6 months after the health check
75. RARER 4 2005 2011 7 222 255 eGFR I 2005 4 MPO 2011 EE 7 2 4 E HE 2011 CKD
76. haces Eo pni B EA Vol 29 No 3 2014 Selvin 0 BEAR IERS BO i BA RODD Ge 35 493 Nagata 7 39 000
77. EL REKE JA SEHR WH Hi 150 62 520 Vol 29
78. 56 2015 7 H 30 CR 31 2 56 2025
79. Official Journal of Japan Society of Ningen Dock Cl 6 RF
80. 12 470 2010 24 1163 1168 3 Steinberg D Parthasarathy S Carew TE et al Beyond cholesterol Modifications of low density lipoprotein that increase its atherogenicity N Engl J Med 1989 320 915 924 4 TE 2007 22 694 708 5 3 W d ROMs Heart View 2012 12 273 278 6 1 2002 17 52 55 7 Isogawa A Yamakado M Yano M et al Serum superoxide dismutase activity correlates with the components of metabolic syndrome or carotid artery intima media thickness Diabetes Res Clin Pract 2009 86 213 218 8 Cesarone MR Belcaro G Carratelli M et al A simple test to monitor oxidative stress Int Angiol 1999 18 127 130 9 Benzie IE Strain JJ The ferric reducing ability of plasma FRAP as a measure of antioxidant power the FRAP assay Anal Biochem 1996 239 70 76 Ishizaka Y
81. 49 20 9 11 12 50 21 9 3 4 ps c 51 22 8 26 27 W E iE 52 23 8 25 26 Elo CIS 53 24 9 1 2 54 25 8 29 30 9t WHE PE RRR Ra bE 55 26 9 4 5 Vol 29 No 3 2014 69 527 1 Letters to the Editor RET 1964
82. 9 5 E PL 0 02 IR EHI EAR PL P 02 OCT PL O 01 1 PL O 03
83. 2 1 BRS TH LDL C LDL C ABER PE gt Bre 1
84. 1 IL 0 012 p 0 020 A CON Sp E res oe SEU ED ae campylobacter pyloridis 1983 Warren Marshall L BEB B MALT Mucosa Associated Lymphoid Tissue CORB 20 30 90 2013
85. 1 Cr eGFR 0 76 0 16 80 9 14 3 0 83 0 13 0 63 0 09 80 6 14 0 81 5 14 9 REA 0 79 0 17 79 7 15 4 0 85 0 15 0 65 0 13 79 0 15 2 81 4 15 9 2005 0 79 0 15 77 1 12 8 0 85 0 13 0 64 0 09 77 5 13 0 76 0 12 3 2005 0 82 0 18 75 4 15 2 0 87 0 16 0 66 0 11 75 5 15 1 75 1 15 4 120 19 75 15 5 2 1 6 SO REA 123 18 77 12 5 4 1 6 2005 120 19 75 16 5 3 1 4 2005 124 16 77 11 5 5 1 3 2005 2011 Vol 29 No 3 2014 33 491 2 Cr eGFR ZA 21 2 2 2005 2 4 5 6 8 9 29 5 4 0 7 6 11 2 20 3 12 2 20 4 29 0 33 8 2006 2 6 3 7 9 6 24 1 4 6 6 9 12 1 19 0 11 4 19 7 24 3 35 2 2007 2 3 4 4 9 8 19 9 4 2 6 3 11 4 19 9 12 1 20 2 26 5 38 4 2008 2 8 5 4 10 2 22 6 4 9 7 6 12 0 17 5 13 6 23 4 30 5 40 0 2009 3 8 6
86. 2008 273 281 2 Kaplan NM Measurement of blood pressure In Kaplan NM ed Kaplan s Clinical Hypertension 7th edit Lippincott William amp Wilkins Philadelphia 2002 25 55 4 URL lt 1 2006 http www mhlw go jp topics tobacco kin en sien manual index html 2012 03 02 2 Ministry of Health Labour and Welfare Fact sheet of abridged life tables for Japan 2010 2011 In Japanese http www mhlw go jp toukei saikin hw life life 1 0 index html accessed July 28 2011 5
87. i E E fins Seed 10 000 6 000 30 000 T 102 0075 9 15 1F Tel 03 3265 0079 Fax 03 32
88. 24 4 OCR 1 7 100 2007 4 E 4 23 481
89. E N 17 4 3 41 2 7 4 3 RERA 72 16 79 12 83 3 60 4 4 1 5 0mg HR 20 8 5mg dL 2 1 121 2 1 1 2 1 7 3 20
90. 18 18 20 30 WE 3 PAMIETA 1 gt 5 1 3 3 4 4 22 5937 187 6 19 304 3 1
91. 2 3 T 113 8655 7 3 1 Tel 03 3815 5411 Fax 03 5800 9845 26 484 Vol 29 No 3 2014 PEO Ai Bob Ba ZONE SES 2008 1 2011 1 P 68 34 82 59 63 1 L
92. 42 500 A HE v2 3
93. 6 WEB HKG EoE 55 2014 9 4 MES 2 ml H 1 Dobbins JW Sheahan DG Behar J Eosinophilic gastroenteritis with esophageal involvement Gastroenterology 1977 72 1312 1316 2 Landres
94. 38 496 T 861 4193 5 3 1 Tel 096 351 1011 Fax 096 351 8782 Vol 29 No 3 20144 65 100 2011 4 1 2012 3 31 34 041 8 572 347 308 X AF 39 YIRE
95. A B 347 8 572 308 39 CT 211 B BNP 136 271 6 2 5 RRR 23 4 1 2 6 Ajzen
96. ATE 13 7 8 13 6 Bok A 17 A 13 15 12 4 3 45 A B 35 n 347 30 25 20 15 Bigs Ies 0 AH BRE ABE B ARE BH A B ARE B
97. 19 ib 6 54 2013 8 X dA 1 2013 5 2 http www ningen dock jp wp commo
98. 9 10 COT COT COT 11 5 6
99. 1 f ARTAS 3E PS 52 A AA X E A x E 4 OM E Eg 1 1 1 6 1 3 23 Vol 29 No 3 2014 Ei zx nd AO TER 00 5847 BER at X 4 859 2
100. 20 ACL A 24 482
101. G6 Um 3 1 2 6 3 oe 4 5 6 db FE 26 3
102. LAT 3 1 2 3 4 5 6 7 8 9 10 11 2010 58 101 103 13 3 29 1 16 12 28 17 6 29 20 12 1 14 3 27 1 16 12 28 20 12 1 14 6 17
103. 2 I II p 0 020 I p 0 012 1 1 IL 2 3 Meme te D WH MEO RECO glycocalyx complex WV A biofilm CH
104. PETAT A WEN 45 Gh 3k eH 27 45 26 19 E EEDA S 3 44 3 16 193 11 309 2 820 1
105. 5 a l 2 3 b 2 5 c 1 4 5 d 2 3 4 e 3 4 5 24 COPD 1 COPD 2 COPD 3 COPD 4 5 a 1 2 b 1 5 c 2 3 d 3 4 e 4 5 25 CKD Cr 0 4 g gCr 1 70 C 2 eGFR 45 mL min 1 73mm Cr 0 5 g gCr 35 eGFR 55 mL min 1 73mm aA H2 Ww N RF a TL 2 b 1 5 c 2 3 d 3 4 e 4 5 VIII JAPAN SOCIETY OF NINGEN DOCK 560 The 56th Scientific Meeting of Japan
106. S 3 lt Lid RIL 88 92
107. US 3100R aIL 6S z 18 z 1 01 mg dLOE TE 0 81mg dL eGFR lt 60 0mL 25 1 73m 140mmHg 90mmHzg 7 0mg dL CH TUY ZREZEK WPW eGFR 2 Z 5 ELK IV IV THY
108. 2 NADPH oa 7 ee NO Vol 29 No 3 2014 7 465 1 SOD 8 8 OHdG Cu Zn SOD 8 Mn SOD AGEs LDL C S reactive oxygen metabolites test d ROMs diacron reactive oxygen metabolites d ROMs
109. 2009 25 47 5 FEE ASIN 2011 121 6 2010 1 2 7 2013 28 84 89 8 GB BS 3 2004 137 9 2011 115 10 E 23 X 2014 1 30 2014 5 30 Vol 29 No 3 2014 Study on Improving Accuracy of Medical Interviews Yuki Rokuta Emiko Morikawa Hiromi Ishimoto Toyomi Maeda Micaru Eguchi Yumiko Yuasa Kinuko Ushijima Tetu Kawagu
110. 3 6 7 30 100 30 70 Vol 29 No 3 2014 71 529 20 10 1 100 8 ml EDO ROA 4 8 Letters to the Editor 1 T e B 9
111. PL P 06 2011 S http www ningen dock jp system fellow http www senmoni jp e 26 26 10 19 13 00 15 00 14 40 11 30 1 2 3 13 JR 3 fh 100 1 100 1
112. 3 GET 5 1 5 A B LZ 3 PS ATE B X 1 E B B A m 2 f b o 8 BH B P S 5 ke BH B S 5 5 B X E
113. 55 Lessons for the Nation 26 9 4 5 2 6 uA Lessons for the Nation LT
114. H 30 000 15 T RS 2010 X 30 9 27 6 ETORB XX X iB MMG US 2009
115. 1 2 3 MCV 4 MCV 5 MCV a 1 2 3 b 1 2 5 c 1 4 5 d 2 3 4 e 3 4 5 VII 21 1 30 0 3 BE K amp S MRA 3D CTA 90 oan c 22 2 1 a b IRZ E c H5N1 d e C 23 X 1 2 3 4 X
116. 1 2 6 3 A BE 5 423 A B 509 A CH 1 639 FS Bld 28 7 599 OR 1 25 R 25 CE OF 2 25 1 25 2 25 3 25 4 3E DOF 3
117. 1 34 8 23 24 2 35 8 13 3 2 la 36 9 29 30 2 4 AUR aur 37 9 8 9 EE 5 38 8 22 6 39 8 27 28 7 140 8 26 27 8 A 41 9 8 9 Penk Bete B 42 9 8 9 9 43 9 20 21 10
118. 1 5 12 396 2005 LT 2011 2 4 gt 9 1 16 3 gt 4 1 8 6 eGFR 7 1 13 7 gt 8 0 13 2 34 492 2005 201144 IC RBA 4 CKD 3 3380 CKD 2005 3 5 15 1 Vol 29 No 3 2014 20 a i ob 28 ad d o Cr eGFR
119. 2005 2011 2011 Ch CKD 4 RES BRR CKD
120. 3 4 4 SRR Conflict of Interest b 1 2 Tmdex Medicus 4 3 eta 1 RL 2008 23 23 28 2 Ozaki S Atarashi K Minami M et al Effect of aging and body weight changes on serum uric acid Ningen Dock 2008 22 43 48 3 1 EL
121. 38 5 IgE 3 1 2 1 RAIA 4 4 yd 3 AWC REO DR 1 1 2 EoE 2 REEBOK CT 3 1 1 2
122. TEZ 70 HPF c d HE X400 b 1 4 HPF p 0 11 i Kinoshita 77 EoE BY EoE 6 4 3 Kinoshita 5 46 Abe 25 EoE
123. 26 5 8 z s i EE 5j B M I B Ki 2 M de od He HE 7 R E E OZ HA 1 1 1 X 2 m X 4 8 z SUERA BAEK RBCS EHO IEO Et E FA HDL LDL Friedewald AST GOT ALT GPT y GT y GTP A L P 75g 3 0 60 120 HbA1c RN le M C V M C H M CH C C R P WA ABO
124. fluticasone budesonide H 5 fluticasone EoE i 2007 Furuta EoE 1 Proton Pump Inhibitor PPI EoE PPI 20110 30194 p O Wr Pv 4 ei PPI PPI PPI responsive esophageal eosinophilia PPI REE E LT EoE 2 EoE EoE PPI EoE PPI Eo
125. 1 190 110mmHg 45mm 45mm 20mm 7mm 1 10mm T hrs Vol 29 No 3 2014 T 861 8528 2 1 1 Tel 096 384 3100 Fax 096 387 6876 19 477 2 1999
126. 1 2 3 US pH 2013 28 3 516 523 2 BARNA Eiko Takahashi Kengo Moriyama Minoru Yamakado and the Ningen Dock Database Group 1 Japan Society of Ningen Dock Academic Committee 2 Department of Clinical Health Science Tokai University School of Medicine 3 Mitsui Memorial Hospital Lifestyle and Blood Pressure Control in Japanese Adults Receiving Hypertension Treatment An Analysis of the 2009 Japan Society of Ningen Dock Database Ningen Dock International 2014 1 70 77 55 A x i N 3 55 427 24 5 6 2
127. 3 HbA1c BAP 40 50 BAP C do Z SAB VAT BS HRB ARATE max IMT d ROMs B R CRP 6 d ROMs BAP Vol 29 No 3 2014 9 467 B R 2030 40 50 60 70 k KF amp R R 80 2030 40 50 60 70 80 RE RERE 6 BAP d ROMs B R 3 d ROMs BAP p d ROMs Carr U 352 66 336 59 380 69 lt 0 0001 BAP uM 2307 218 2284 226 2346 199 lt 0 0001 BM
128. LDL HDL TG HOMA IR UA TG UA TG UA 10 468 AFE B RIEZ 8 5 BE 6 6 8 4 CHE 6 5 B R 3 B R 8 5 A B R 6 5 C B R 6 6 8 4 B 3 4 C T Bil T Bil 4 Vol 29 No 3 2014 1800 p 0 0041 N o 1600 PWV cm sec 1500 1400 Bat n 375 C n 219 A n 166 IMT mm 2 3 p 0 0175 C n 219 A n 166 Bat n 375 7 B R 3 PWV IMT 5 B R Eun otal pii BMI lt 0 0001 hs CRP lt 0 0001 lt 0 0001 LDL HDL 0 0129 lt 0 0001 TG lt 0 0001 NS HbA1c lt 0 0001 0 0303 HOMA IR 0 0030 NS IMT lt 0 0001 NS
129. 1 2 3 1 2 3 4 1 2 3 4 Vol 29 No 3 2014 53 511 2 A 1
130. 61 8 66 7 2 271 A 197 BH 74 117 43 2 55 6 11 0 100 A 88 44 796 B 12 16 2 A B B 12 B A Ou 3
131. 25 2013 BU 6 55 513 X B D
132. EoE M ller 117 EoE ABE 26 D 19 LAL 25 Mackenzie iX classic EoE 42 Miller EoE 6 DS 5 5 Gonsalves Id EoE sensitivity
133. Rh P He xs HBs E PH R dis i it KA i 1 if 2 sk dt gB m g 22 WSL ED PSA K HCV itk XX XX Vol 29 No 3 2014 67 525
134. 9 903 1 381 11 284 2 Vol 29 No 3 2014 T 107 6206 9 7 1 6F Tel 03 5413 0080 Fax 03 5413 7915 45 503 EoE fr 6 4 2 1 2 retrospective wy f m RIC
135. 39 10 11 17 8 6 6 4 12 2 0 13 0 4 2 4 0 3 0 3 1 2 0 0 ABE ARt BEE A BEF A Bat ABE BEE ABE BEF 6 8 5 1 15 2 16 0 12 13 3 0 1 0 0 0 1 2 0 0 2 0 1 2 Vol 29 No 3 2014 41 499 100 BAH ARBRE 100 n B 80 60 40 0 e X BH BH n E R 2 ft pe 23 7T HB 9 B PB t hk R 4 9 6 8 B 1 B Wu 5 5 F B RIE amp E T E SF amp g 2 amp c B Rz B C E BH E g BR ER R m B H5 C a UL E gm Ek d kB o E A 2 TEA B t 2 fr E E HSER
136. 1 2010 6 A 2010 4E BE 2 6 5e RZ 1 RA EOS LZ CU HA 20114 T 305 0005 1 2 Tel 029 856 3500 Fax 029 856 3515 Vol 29 No 3 2014 13 471 1 2009 m 1 Shap eh 4 2077 U 4 5
137. 6 3 A 5 423 A B 509 CSE 1 639 amp 28 7 99 150 58 516 SAIC
138. CHERAB OIE 2012 7 10 17 2014 3 17 2014 7 23 Analysis of Determining Factors in Motivating Follow up Subjects to Undergo Further Examinations Maki Hamanosono Yuuko Araki Yumiko Shimohara Nozomi Fukushima Kaori Sakata Moritaka Suga Saiseikai Kumamoto Hospital Center For Preventive Medicine Abstract Objective At our center among subjects deemed to require further examinations and medical treatment further examination candidates on the basis of health check up results those suspected of having malignant diseases and those with abnormal test results follow up subjects are actively encouraged to undergo prompt examination at medical institutions In the present study we analyzed factors determining whether persons undergo further examinations or not in order to raise further examination rates Methods Our subjects were 347 follow up subjects 308 who underwent further examinations 39 who did not among 8 572 further examination candidates in the period April 1 2011 March 31 2012 Backgrounds of follow up subjects undergoing further examinations were analyzed based on medical interview findings For follow up subjects undergoing further examinations motivational factors were evaluated by means of a questionnaire survey with re
139. 23 501 1 1 61 20413351 3 83 2 1 26700 2 3 86 1 3 10 3 1 2 3 70 25 513 1 1 23 2 131 3 4 4 26 2 1 2 81 1 336 1 4 9 2 3 10 2 4 107 3 4 3 3 1 2 3 14 1 2 4 57 1 3 4 1 2 3 4 7 4 1 2 3 4 36 D Fed
140. 29 501 0 52 28 975 0 51 31 362 0 55 31 235 0 55 32 446 0 57 33 415 0 56 35 321 0 56 2005 2011 16 728 1 00 0 40 2005 46 54 10 86 2005 2011 Iu ERES BEBE T ind SA 32 490 T 950 0965 11 1 Tel 025 283 3939 Fax 025 283 3974 Vol 29 No 3 20144F 2011 2005 CKD CKD CKD CKD REAK AL A2 A3 Q4 UbK EBAMZ RE C
141. CagA cytotoxin associated A v 50 70 2 CagA VacA Vacuolating cytotoxin A ESS CagA VacA BERKER o HOREA v MEE LJE WHC I II pen Ikr
142. Vol 29 No 3 2014 EoE EoE REJ 2 47 505 SS SOAR SRA ABESIS eosinophilic microabscess EoE EoE
143. 1 1 E mail FAX 7 B 56 JTB T 141 8657 2 24 9 3F Tel 03 5434 8759 Fax 050 3730 3977 FAX E mail 56jsnd jtbcom co jp y Vol 29 No 3 2014 A 55 55 Sia GB gU
144. 2 355 1 477 59 6 10 3 87844 59 2 10 6 d ROMs BAP Accute SHAPE 10 CV 1 0 0 4 2 7 1 0 BAP CV 1 6 2 3 3 3 2 7 4 d ROMs BAP d ROMs 336 59 380 69 Carr U Ex BAP 2 284 226 2 3464199 u M 5 d ROMs BAP d ROMs
145. 2 FREER 6 2005 4E 4E LZ RARE 3 73 5 7c jf C 2011 c REB GEILE 407 o gt 354 m gt 304 2544 204 CL np 98 3i d Cr eGFR 3 FREER 6 2005 4E 2H ELT RARE 2011 T 22 596 27 4 74 0 57 5 9x
146. E 55 55 26 9 4 5 16 193 11 309 4 859 2 820 60 518 Vol 29 No 3 20144F OFM 26
147. EPS extracellular polysaccharide 2 x BAZO 4 9 13 18 23 41 p 0 49 22 32 54 BAZO 8 21 29 14 11 25 p 0 03 22 32 54 27 485 VI 3 63 0 5 5 2403 p 0012 II te 1 1 I 49 4410 7 18 2 7 0U mL p 0 020 180 E E TS 2 120 ia S i a o ia o 36 5 7 8 14 0 9 6U mL p 0 077 180 a E SS 2 120 ia jid mi Uu 60 45 0 Vl E 4 5403 5 1 0 4 p 0 377 II te 2
148. s ACSH P AETERNA a AMD TERN TR A ENS AOE 3 A AICS i 0 0 10 0 AICS AICS 0 0 4 9 5 0 7 9 a COUNTS ORC ne gcn AICS A B C 3 EDDIE vB 1 1 000 0 19 AICS A 1 3 200
149. V Hy d LU s m w X Wu Vol 29 No 3 2014 81 539 n E gt COT
150. S 4 1 26 12 1 A 27 3 13 50 30 80 11 80 1 50 30 11 senmoni ningen dockjp H24
151. B 3 B 9 B 4 B 10 B 5 B 11 B 6 C C C 2 Ge C 3 Cex C 4 Cs 9 Ces C 10 D D 1 Ningen Dock International B 56 JTB T 141 8657 2 24 9 3F Tel 03 5434 8759 Fax 050 3730 3977 FAX E mail 56jsnd jtbcom co jp B 2015 4 1 CK 20155 6H 18H A B o 8
152. 3 4 25 1 2 3 4 1 2 3 4 DVD 1 2 3 4 DVD 1 2 3 4 1 2 3 4 5 6 IT
153. 6 GAR SEP UP Bg pe CREBR L 7 EBRSKTE RGB 7 eosinophilic esophagitis EoE 6 H o v gt T B RE ERA Z 2012 10 2014 2 6 EoE retrospective 38 5 4 2 3 4 3 1 2 EoE gt 20 HPF
154. 2 3 4 600 4 ABRE 250words Objective Conclusions 4 SAK Methods Results Conflict of Interest I 1 1 Vol 29 No 3 2014 79 537
155. FAX 1 NR Fly te a ee 29 3 24 2013 5 1 1 1 5 5 2 000
156. 1650 1568 2063 1858 j 433 476 1011 1000 26 2 30 4 49 0 53 8 27 6 10662 11029 11706 11667 596 576 429 459 482 536 411 439 80 9 93 1 95 8 95 6 14 7 8885 9444 9601 9475 azmgas 182 303 187 149 FEM 120 227 146 122 65 9 74 9 78 1 81 9 16 0 MEX BIS CT ee 2009 2012 3 7K kea 3 X BASH Bx 2011 65 9 65 9 46 7 47 3 79 5 66 3 57 3 66 3 75 0 53 1 49 0 95 8 78 1 61 7 2012 68 9 71 3 56 7 51 3 69 3 75 2 61 4 77 8 76 8 68 2 53 8 95 6 81 9 69 1 2009 2010
157. 5 a 1 2 b L5 c 2 3 d 3 4 e 4 A 5 zm Gant n o c 0 c amp 6 a b c d e 7 lex 1 100 30 2 3 cm 1 1 HbA1c 12
158. Microsoft Office Dd ze 6 12 000 4 8 000 8 16 000 Letters to the Editor 1 200 1 SI kg g mg dL L mL m cm TRE 3 1 234 567 890 A4 1 400 1
159. 3 6 3 2 2010 2011 2012 HTS X AXP 2009 2012 X 30 9 Vol 29 No 3 2014 15 473 2 2009 2012 2009 2010 2011 2012 ic an 31719 32102 33762 34348 z 1477 1057 1211 1233 BBB Xie 792 587 803 959 53 6 55 5 66 3 77 8 24 2 6425 6716 7240 7955 SKRE 447 484 536 512 295 342 402 393 66 0 70 7 75 0 76 8 10 8 19701 19487 20323 19959 X 386 675 503 261 144 260 267 178 37 3 38 5 53 1 68 2 30 9 26804 27181 28746 29245
160. 50 50 vs p lt 0 0001 vs p lt 0 0001 vs p 0 0006 7 5 vs p 0 0034 vs p 0 0235 7 0 NS vs p 0 0132 B R 6 5 n 348 n 656 n 229 8 n 445 n 726 n 305 Ek CHE TC TG HDL C 7 3 PWV IMT PIL CHE PWV IMT B R Vol 29 No 3 2014 n 622 n 71 n 25 n 735 n 91 n 46 B R hs CRP LDL HDL TG HbA1c HOMA IR IMT BMTI hs CRP LDL HDL HOMA IR
161. A B A 211 B 136 A 97 7 206 du E HL B 72 9 99 AFE B 100 A 95 1 3 TER 85 796 88 9 2 3 i n 8572 n 347 4 n 308 n 39 PIE Fa 50 6 10 8 50 6 11 3 51 2 11 5 46 3 8 7 p 0 05 5136 59 9 220 63 4 192 62 3 28 71 8 3436 40 1 127 36 6 116 37 7 114 28 2 6810 79 4 246 71 9 226 73 4 20 51 3 A 1328 15 5 70 20 2 54 17 5 164 41 0 p lt 0 05 434 5 1 26 7 6 28 9 1 34 7 7 0 0 0 5 1 496 50 16 2 13 33 3
162. RRA itl 98 556 AR FY Vol 29 No 3 2014 aminoindex AICS 1 AICS AICS AICS 4 genesi BAA Bb AMAA RUD FEMA BRA ZUEAICSI2RE AAA TENA BRE
163. AICS AICS 25 90 40 90 20 80 AICS 8 AICS 138 EDTA 2Na aminoindex SIRIL eee Communication for Health TEL 042 646 5911 e Mail di srl inc co jp http www srl group co jp 4408 SP
164. T 16 8 RD DS H Li
165. I The 56th Scientific Meeting of Japan Society of Ningen Dock iB 1 PL I ABC B I
166. 17 6 29 19 15 20 7 31 15 8 10 21 13 3 29 E6 29 20 12 1 E12 1 E6 17 E7 30 4 COI 224 E3 27 UNESCO October 16 2003 E3 24 E12 1 E2 E 20 3 1 16 2 16 12 E8 16 20 12 1
167. ZH A x 1 1 57 515 COSS 1 25 R 25 CE Bld OF 2 25 R 1 25 R 2 25 9 3 25 E 4 R OF 3
168. 73 LDH lactate dehydrogenase 74 LDL C low density lipoprotein cholesterol IER RRA IL ATU 75 Lp a lipoprotein a J SR EI a 76 LPL lipoprotein lipase 77 MCH mean corpuscular hemoglobin 78 MCHC mean corpuscular hemoglobin concentration 79 MCV mean corpuscular volume 80 METs meatbolic equivalent 81 MetS metabolic syndrome 82 MMG mammography 83 MRA magnetic resonance angiography 84 MRI magnetic resonance imaging 85 mRNA messenger RNA 86 MRSA methicillin resistant Staphylococcus aureus 87 MSW medical social worker 88 NMR nuclear magnetic resonance 89 PET positron emission tomography 90 PSA prostate specific antigen 91 PTH parathyroid hormone Fall FCT aR UE v 92 PWV pulse wave velocity 93 QOL quality of life 94 RBC red blood cell 95 RF rheumatoid factor 96 RI radioactive isotope 97 RIA radioimmunoassay
169. 2 16 12 28 17 6 29 19 8 16 20 12 1 15 7 30 255 16 12 28 20 7 31 15 8 10 UNESCO October 16 2003 21 3 24 21 11 2 22 12 1 23 2
170. E 255 16 12 28 E4 12 10 25 12 13 Vol 29 No 3 2014 73 531 1 Gu Letters to the Editor 1964
171. 10 ADL activities of daily living 11 AFP a fetoprotein a 12 ALP alkaline phosphatase 13 ALT alanine aminotransferase 14 Apo a apolipoprotein a TR RAE a 15 APTT activated partial thromboplastin time 16 AST aspartate aminotransferase 17 BMI body mass index 18 CA125 carbohydrate antigen 125 125 19 CA19 9 carbohydrate antigen 19 9 19 9 20 cAMP cyclic adenosine 3 5 monophosphate 3 5 21 CAPD continuous ambulatory peritoneal dialysis 22 CBC complete blood cell count 23 Ccr creatinine clearance 24 cDNA complementary deoxyribonucleic acid 25 CEA carcinoembryonic antigen 26 cGMP cyclic guanosine 3 5 monophosphate 3 5 27 ChE cholinesterase 28 CKD chronic kidney disease 29 COI conflict of interest 30 COPD chronic obstructive pulmonary disease 31 CK creatinine kinase
172. 2008 273 281 2 Kaplan NM Measurement of blood pressure In Kaplan NM ed Kaplan s Clinical Hypertension 7th edit Lippincott William amp Wilkins Philadelphia 2002 25 55 URLI 1 2006 http www mhlw go jp topics tobacco kin en sien manual index html 2012 03 02 2 Ministry of Health Labour and Welfare Fact sheet of abridged life tables for Japan 2010 2011 In Japanese http www mhlw go jp toukei saikin hw life life 10 index html accessed July 28 2011 c 2 CD ROM 1 5
173. 5 NIPPON DATA80 a l 2 3 b 1 2 5 c 1 4 5 d 2 3 4 e 3 4 5 VI 17 D2 1 TH GRA 10 mm T Tif i WN 0 C 0o amp 18 1 123 a 50 b 50 c PSA 4 0 ng mL d PSA 1 1 ng mL e PSA 0 0 1 0 ng mL 3 19 1 a 2 PB 3 4 Ca Hpi 5 ACE a 1 2 b 1 5 c 2 3 d 3 4 e 4 5 20
174. HITEH EP ETA 5 2 24 e learning 3 20 6 5 1 106 25 4
175. 6 Vol 29 No 3 2014 6 Wb WE
176. BSE 34 719 OREI d ROMs BAP d ROMs BAPTA B R m T BA III En p f 1 1996 8 12 H18H http www 1 mhlw go jp houdou 0812 1217 4 html 2014 8 7 2
177. 1 FeCl AT FeCl AT 2 FeCl AT BP e FeCl AT BP AT RE REO 477 VBE FeCl FeCl AT 088 BP e BP BP e FeCl BP e LE 3 d ROMs BAP d ROMs BAP 2 d ROMs BAP Fe Fe d ROMs BAP
178. 5 50 B R 8 11 469 d ROMs BAP d ROMs BAP B R a PWV IMT
179. B 1 625 C 1 98 A B C prid odd n to 00 49 50 739 Bh 1 3200 036 1 625 1 6 1 2963 038 1 536 1 9 1 2 000 0 5 1 789 1 3 1 2 222 0 5 1 469 2 1 EN 1 1509 0 78 1 556 1 8 1 EBEN 1 4000 036 1 682 1 5 5 B 1 6 C 10 2 1 CURE Tia 80 AICS xe 5 0 959 6 AICS 8 0 AICS B 00915 E 0 3496 RAE 5196 0 9396 AICS 00669 80 73 0 24 95 45 0 60 BANA E AME 3 26 G 454 2662O11 E 0 o 0 0 9 9 9 F 26 5 749 755 2012 A Sia 0 0844 80 60 0 25 95 41 0 69
180. EoE 3 1 2 3 fiv 1 1 2 EoE tf eosinophiic esophagitis EoE 1977 Dobbins eosinophilic gastroenteritis 1978 Landres 5 EoE 1993 Attwood 5 28 20 High Power Field HPEF 12
181. 1 RERA 73 d ERY v b gt ERE CHS CO ACH LZ BENZ WMHS Zou PCR v 28 486 26 2000 Miyabayashi
182. 81 32 149 304 163 24 9 103 10 4944199 50 lt 99 120 100 196 22 2 228 3 5 282 6 9 66 10 19441 20 5 18 334 290 16 RA 1 A B c D E F G H 1 0 204 0 192 0 367 2 0 159 0 161 0 193 3 0 167 0 257 0 116 4 0 112 0 211 0 171 0 136 5 0 196 0 169 0 153 0 107 6 0 082 0 182 0 172 0 215 0 144 7 0 195 0 160 0 085 8 0 198 0 120 9 0 101 0 100 10 0 116 0 130 11 0 085 12 0 097 13 0 165 0 109 0 101 15 0 108 16 0 116 0 092 17 0 165 0 109 0 101 18 19 20 0 142 0 099 21 0 149 22 24 0 166 54 512 Vol 29 No 3 2014 5
183. 98 RNA ribonucleic acid 99 SBP systolic blood pressure 100 SD standard deviation ER ne 101 SEM standard error of the mean 102 STD sexually transmitted disease 103 T Bil total bilirubin 104 T triiodothyronine 105 T thyroxine 106 TC total cholesterol 107 TG triglyceride 108 TIA transient cerebral ischemic attack 109 TIBC total iron binding capacity 110 tPA tissue plasminogen activator 111 TPHA Treponema pallidum hemagglutination assay 112 TSH thyroid stimulating hormone 113 TTT thymol turbidity test FE VE AR 114 UCG ultrasonic echocardiography 115 UIBC unsaturated iron binding capacity 116 UN urea nitrogen 117 VLDL very low density lipoprotein RICE Y RAE 118 WBC white blood cell 119 WHO World Health Organization 120 ZTT zinc sulfate turbidity test 96 554 Vol 29 No 3 2014
184. gt ID No 1 a 1 b 2 c 3 d 4 e f 2 3 a ER b 4 a b c d e
185. MM gp M i aen 10 11 5 6 8H 9H 12H 3 8 12 ScholorOne Manuscripts http mc manuscriptcentral com ningendock 151 0051 5 8 10 605
186. 1 19 3 E V K RH fi eee AB 2 TERRES 19 4 19 4 Te RM Ae uA St 19
187. 1 50 1 200 ORFSNEE CORR 1 200 Ome 1 5 Vol 29 No 3 2014 85 543 INSTRUCTIONS TO AUTHORS Ningen Dock International Official Journal of Japan Society of Ningen Dock Ningen Dock International is the official journal of Japan Society of Ningen Dock in which original articles case reports and review articles in both Japanese and English are published Ningen Dock accepts only manuscripts that are original work in the field of ningen dock and related areas not previously published or being considered for publication elsewhere except as abstracts The manuscripts published in Ningen Dock will appear on the website of our society If the manuscript concerns a clinical study it must be in accordance with the De
188. 10 72 12 F 121 1 7 1 1 24 65 24 1 24 70 59 1 58 796 80 50 7 46 4 E 24 25 352 70
189. 32 CRP c reactive protein C 33 CT computed tomography 34 CVA cerebrovascular accident 35 D Bil direct bilirubin 36 DBP diastolic blood pressure 37 DNA deoxyribonucleic acid 38 DRG diagnosis related group 39 dsDNA double stranded deoxyribonucleic acid 40 EBM evidence based medicine 41 ECG electrocardiogram 42 eGFR estimated glomerular filtration rate 43 EIA enzyme immunoassay 44 ELISA enzyme linked immunosorbent assay 45 EPO erythropoietin 46 ESR erythrocyte sedimentation rate 47 FBG fasting blood glucose 48 FDA Food and Drug Administration 49 FEV forced expiratory volume 50 FEV forced expiratory volume in one second 1 51 FEV forced expiratory volume in one second 1 52 FPG fasting plasma glucose 53 FSH follicle stimulating hormone 54 FT3 free triiodothyronine 55 FT4 free thyroxine 56 FVC forced vital capacity
190. 7 1 2 3 4 1 2 3 1 2 3 4 e learning 1 2 3 e learning 1 2 3 4 1 2 3 4 5 2 1 1 2 2 3 3 1 3 1 2 3
191. 2 208 8 7 14 70 4 9 10 3 8 2005 H OCR 1
192. 8 466 Vol 29 No 3 2014 2 d ROMs BAP d ROMs n 10 n 10 Sample A B C D Mean Carr U 222 560 156 367 SD 2 1 2 4 4 2 3 5 CV 96 1 0 0 4 2 7 1 0 1Carr U 0 08 mg dL H O BAP n 10 n 10 Sample A B C D Mean uM 2135 2625 2357 3483 SD 33 7 61 0 79 0 93 0 CV 96 1 6 2 3 3 3 2 7 336459 vs 380469 Carr U p lt 0 0001 180 22844226 vs p lt 0 0001 2346199 uM 300 n 878 n 1477 n 1477 n 878 300 180 120 200 4 w SE R 120 100 100 0 0 1500 30 4X 50 d ROMs Carr U 200 100 300 400 500 d ROMs Carr U 600 T T 0 1800 2100 2400 2700 3000 1500 BAP uM 1800 2100 2400 BAP uM 2700 3000 4 d ROMs BAP 350 S 3407 320 x gt 310 20 30 40 50 60 70 80 20 30 40 50 60 70 80 ak ak 5 d ROMs BAP 80
193. T 5 1 EocE 2 app 5U EoE O3 SELL 7 DUE BG LT SCL EE lgE Kinoshita ix 26 EcE 50 6 3 1 6 228nL 61umL EoE Fujishiro 5 000 1 Eo 9 903 Bl 1 381 4 2 EoE 2 476 1
194. eam 3 9x iX CE 3
195. 5 5 1 S y 2014 24 2013 24 00003 5 2013 4 1 2018 3 31 2013 25 00170 5 2014 4 1 2019 3 31 2014 9 26 10 1 K 11 28 2 000 OA ES 25 2 000 RURAL dens 11
196. 8H 9H 12H 3 8 12 Expack T 151 0051 5 8 10 605 03 3354 2004 FAX 03 3354 2017 E mail sadoku scientist press com 1 V V
197. EoE HE EoE 10 10 BA 50 10 200748 2011 2013 2 EoE 2006 Furuta EoE 2010 EoE Dill H d PERE TEE 20 HPE LAL Abe HE gt 20 HPE 12 EoE 3 EoE 6 3 2012 10 1 2014 2 28
198. 12864 15 0 634 18 296 554 17 9 4 10 3 1734 20 3 59 17 0 49 15 9 6 15 4 1848 21 6 55 15 9 28 9 1 34 7 7 278 3 2 31 8 9 14 4 5 3 7 7 337 3 9 17 4 9 10 3 2 34 7 7 302 3 5 13 3 7 m 14 4 5 0 0 0 334 3 9 14 4 0 14 4 5 1 2 6 492 5 7 15 4 3 6 1 9 0 0 0 3 0 03 0 0 0 17 5 5 1 2 6 148 1 7 6 1 7 16 5 2 24 5 1 578 6 7 18 5 2 25 8 1 24 5 1 307 3 6 18 5 2 10 3 2 14 2 6 771 9 0 27 7 8 771 9 0 27 7 8 145 1 7 11 3 2 145 1 7 11 3 2 100 00 an W M BM E 79 4 82 4 76 9 60 40 20 0 A ANT Pe OS OS E SF ae un AN NE S x wy P AW x 9 FS amp d sw amp Vv 1 40 498 Vol 29 No 3 2014 B
199. M C V M C H M CH C C R P ABO NAI Rh HBs Hi E E PH E T Wm it it KA i E ie 2 f de d H mu 2 WPL HS PSA FRE K HCV XX X 66 524 Vol 29 No 3 2014 2
200. 1 PPI 2 EoE EoE EoE EoE Straumann 5 lk 30 EoE 11 5 23 37 37 Vol 29 No 3 2014 3 EoE EoE
201. 3 1 2 3 1 2 3 1 2 3 4 1 2 3 4 1 1 2 1 3 2 3 H 4 4 1 2 1 3 2 3 4 4 15 1 2
202. BR m b id a 5 U EE E o E KR r DR X RH M 5 h m B b b v 6 2 x m 5 Vol 29 No 3 2014 39 497 fu m EAS 2 p lt 0 05 p 0 05 3 mA n2 gt 85 3 82 4 79 4 76 9 1
203. C 2 CREAR LS 5 40 a i 2 b 1 5 c 2 3 d 3 4 e 4 5 2 1 b c e d a RY er s nk amp e 3 123 a HUSHMD HEI b HE c d e EE 4 1 B 2 IgE 3 4
204. Conflict of Interest COI 20 3 31 COI 22 4 12 10 25 12 13 Vol 29 No 3 2014 77 535 n V Z OT r z 2UANlCXA YLC V 3 1
205. 1 sensitivity 55 5 sensitivity 100 EoE 7 3 BIDS 723 IgE 1 2 EoE mu 48 506 1 Spergel 5 ik EoE 77 EoE
206. 17 Vassalle C Bianchi S Battaglia D et al Elevated levels of oxidative stress as a prognostic predictor of major adverse cardiovascular events in patients with coronary artery disease J Atheroscler Thromb 2012 19 712 717 18 Kim JH Baik HW Yoon YS et al Measurement of antioxidant capacity using the biological antioxidant potential test and its role as a predictive marker of metabolic syndrome Korean J Intern Med 2014 29 31 39 10 I 11 12 NS 14 Vol 29 No 3 2014 ARJ FY Z 29 471 476 2014 a DET 2010
207. 2006 AICS 0 068296 8096 64 0 22 95 32 0 4396 2 I Edu up E m Mu icis ie AICS SLBR 0 0822 80 4796 0 19 95 20 0 3396 Zaa ET ee AICSCF amp SME 0 0516 80 80 0 21 95 Oa TESA TRAM ERO CMRI ee TK OF OF nH OK OR aspe C 95 AICS II B x los 6096 4096 2096 9 stagell stagell Ef stageO I II stageB stageO I II stage0O I II 54 135 100 197 71 181 146 327 57 149 116 280 31 103 46 146 28 147 33 165 145 273 201 346 40 519 39 45 389 41 30 32 19 20 53 5899 AICS AICS Ri AICS AICS AICS AICS 26 3 454 466 201 1 C 95
208. 691 1 WE E PU E 1 F m ak ek y o COUE wana PM neu am IER 400 1 38 M 23 5 2 vom AOE ae 247M BA B HRB 260 3 20 40 HPF m m a 7 H 3 43M 25 8 4 gt 20 HPF PP iz 2 435M 26 3 4 3 gt 20 HPF PP garg 5 25 M REX 24 6 3 gt 20 HPF TFAA PPI on _ 7 y B 6 39 M 21 2 29 3 gt 20 HPF PP 46 504 Vol 29 No 3 20144 nS TA JENNI LAAN P hial F 5 a SERIAL ODS b HE f amp X 400
209. 75 0 2 3 760 385 3 E 258 5 0 2 9 13 30 6 79 5 8 15 58 5 151 4 1 38 47 4 18 VE 52 6 20 fF 4 2 17 it 58 8 10 B N 4697 2 1 N 129 66 7 2 2 RMB T VATAOBA AMAA AVE D 2 3 N 385 Hi 38 72 258 0 50 100 150 200 250 300 3 Vol 29 No 3 2014 21 479 5 0 m N 258 4 1
210. 1 1 2 3 4 5 52 510 2 5 6 8
211. 2 4 20 Ww 5 a 1 2 3 b 1 2 5 c 1 4 5 d 2 3 4 e 3 4 5 15 1 a 10 15 232 OS EELT b c d e 16 1 CKD PAD Ag eSILEY s 2 NIPPON DATA80 10 4E TA OO EE SU E E OO RIEMER E V GREK ERRET A 3 1 IHI HI TY 4 HDL C
212. 44 8 28 29 11 45 8 27 28 12 46 8 20 21 13 47 8 25 26 8 14 48 8 24 25 MAH 15 49 8 23 24 16 50 8 22 23 dri dapi 17 51 8 20 21 18 52 8 26 27 F4 sina 19 53 8 18 19 20 54 8 23 24 21 55 8 21 22 22 56 8 28 29 H 23 57 9 9 10 24 58 9 2 3 25 59 8 24 25 26 60 8 22 2
213. 52T AV 1
214. PRA PL O 04 WAS g PL O 05 JA NAFLD PL P 01 E CT PL P 03 PL P 04 FDT PL P 05 2
215. X RIS S TEL 03 3265 0079 FAX 03 3265 0083 E Mail senmoni ningen dock jp 2014 24 l 2 000 ae 2013 5 ae 1 D 5 HPF 400 3 1 10 hL 4
216. 38 for abdominal aortic aneurysms certain exams cancelled for 18 17 for thoracic aortic aneurysms certain exams cancelled for 10 and 72 for unruptured cerebral aneurysms certain exams cancelled for 12 There was one case of exacerbation of symptoms involving hyperkalemia in a person undergoing dialysis The collection of information on the previous day had taken 121 min on average and the medical inter view on the day of Ningen Dock 7 min per person on average Conclusion As a result of risk management conducted in medical interviews there was only one case of exacerbation of symptoms However as the collection of information took a lot of time collection methods should be studied in the future It will also be necessary to raise the skill of center staff in conducting medical interviews Keywords Ningen Dock medical interview risk management Vol 29 No 3 20144F 25 483 ARJ FY Z 29 484 489 2014 J REA MALT Mucosa Associated Lymphoid Tissue
217. 4 4 SRR b Conflict of Interest 1 2 Index Medicus 4 3 eta 1 2008 23 23 28 2 Ozaki S Atarashi K Minami M et al Effect of aging and body weight changes on serum uric acid Ningen Dock 2008 22 43 48 3 1 4 RAEI WP
218. 57 GFR glomerular filtration rate 58 GH growth hormone 59 Hb hemoglobin 60 HbA1c hemoglobin Alc Alc Vol 29 No 3 2014 95 553 61 hCG human chorionic gonadotropin 62 HCV hepatitis C virus C 63 HDL C high density lipoprotein cholesterol 64 HLA histocompatibility leucocyte antigen 65 HPLC high performance liquid chromatography 66 Ht hematocrit 67 ICD International Classification of Disease 68 ICU intensive care unit BIRELE 69 IFG impaired fasting glucose ZEARI S 70 IGT impaired glucose tolerance 71 IMT intima media thickness 72 LAP leucine aminopeptidase
219. 6 14 4 33 2 5 9 10 1 14 8 27 0 12 2 21 9 30 2 38 4 2010 5 2 9 6 18 3 32 8 5 2 7 6 14 5 22 3 10 1 15 8 24 0 29 7 2011 6 9 10 6 17 8 39 4 3 5 7 8 13 9 22 7 8 2 13 5 23 3 29 3 3 8 7 5 12 7 28 4 4 6 7 8 12 8 21 1 11 3 18 2 26 6 34 9 ZA 21 2 2 2005 12 0 21 5 27 1 31 6 13 8 21 2 26 1 28 5 11 6 14 3 21 7 32 1 2006 10 5 19 3 19 7 32 8 14 2 21 2 26 5 30 1 9 8 12 8 13 2 27 9 2007 10 2 18 0 21 8 28 3 13 9 19 8 26 7 31 2 9 7 13 1 16 6 27 5 2008 12 1 21 8 29 6 35 7 13 3 18 8 27 0 29 0 11 4 16 2 20 3 31 9 2009 10 3 20 0 26 5 27 0 13 4 20 9 26 0 32 2 11 0 14 6 22 6 29 4 2010 8 8 14 8 21 5 21 3 13 1 16 5 25 0 28 1 10 0 12 9 17 5 26 4 2011 7 4 13 2 19 2 23 7 12 8 16 6 21 9 31 1 9 4 12 4 17 8 27 5 10 1 17 3 23 3 28 6 13 5 18 6 25 5 30 0 10 4 13 5 18 2 28 8 E d Cr eGFR 1 Sphllcdit SREB Cr 2005 2011
220. 6 41 Akasaka 9 chome Minato ku Tokyo 107 0052 Japan Phone 81 3 3475 5618 FAX 81 3 3475 5619 E mail info jaacc jp Copyright Clearance Center Inc 222 Rosewood Drive Danvers MA 01923 USA Phone 1 978 750 8400 FAX 1 978 646 8600 Vol 29 No 3 2014 97 555 9 4 5 55 ANd BRC EA EIE ERS
221. 68 1 IL 1 Vol 29 No 3 2014 1 L I Os F ED Big fuer PR AV AU Vike Bees Cn B X IB vc dd d o TE J IMT
222. 9 3 10 ik TE xa IT 26 A ul 26 10 1 26 11 28 27 4 1 32 3 31 1 Sk 1 2010 1 1 2015 3 31
223. F k Ubiological anti oxidant potential BAP 7 DIOD d ROMs BAP 3 d ROMs hid ROMs L EU 7 BORE ROMs biological anti oxidant potential test BAP d ROMs R OOH Fe R O Fe OH R O A NH gt R O A NH R OOH Fe gt R OO Fe Ht R OO A NH gt R OO A NH R OOH ANH NN R O d ROMs ROO A NH BAP
224. RT Kuster GG Strum WB Eosinophilic esophagitis in a patient with vigorous achalasia Gastroenterology 1978 74 1298 1301 3 Attwood SE Smyrk TC Demeester TR et al Esophageal eosinophilia with dysphagia A distinct clinicopathologic syndrome Dig Dis Sci 1993 38 109 116 4 Prasad GA Alexander JA Schleck CD et al Epidemiology of eosinophilic esophagitis over three decades in Olmsted County Minnesota Clin Gastroenterol Hepatol 2009 7 1055 1061 5 Furuta GT Liacouras CA Collins MH et al Eosinophilic esophagitis in children and adults a systematic review and consensus recommendations for diagnosis and treatment VoL29 No 3 2014 Gastroenterology 2007 133 1342 1363 6 Liacouras CA Furuta GT Hirano I et al Eosinophilic esophagitis updated consensus recommendations for children and adults J Allergy Clin Immunol 2011 128 3 20 7 Dellon ES Gonsalves N Hirano I et al ACG clinical guideline Evidenced based approach to the diagnosis and management of esophageal eosinophilia and eosinophilic esophagitis EoE Am J Gastroenterol 2013 108 679 692 8 Furuta K Adachi K Kowari K et al A Japanese case of eosinophilic esophagitis J Gastroenterol 2006 41 706 710 9 Fujishiro H Amano Y Kushiyama Y et al Eosinophilic esophagitis investigated by upper gastrointestinal endoscopy in Japanese patients J Gastroenterol 2011 46 1142 1144 10
225. Society of Ningen Dock 1 1205 L316 tL si A 5259 0206 5 Ach 3 2 8 Tel 03 5434 8759 Fax 050 3730 3977 E mail 56jsn http convention jtbcom co jp 56jsnd JTB VER 141 8657 2 24 9 3F dGjtbcom co jp E PATA EER CORRES cece 3 m 4 B S 6 Ewma t o eiees4 amp esttesaikat cscs 8 3 10 The 56th Scientific Meeting of Japan Society of Ningen Dock 56 K 56
226. co jp The 56th Scientific Meeting of Japan Society of Ningen Dock i RN NS SR BEES gA Bac NTT E BA B Bt
227. 000 10 000 13 000 15 000 30 2 56 E 2015 30 7 000 B 7 000 FJ VISA Master JCB AMEX
228. 1 I II CKD CKD du Vol29 No 3 2014 5 463
229. 2 38 45 51 25 5 57 26 FE ERAI E v z2ESSEBHLE RS DEERE E rrrrrrrrrrrrrrrrrrrrererenn 60 26 E 1 eee etree cence tenes 64 26 ba eee C EU 66 26 tees wee IO 67 68 ee td 70 rrTrrTPP 98 Contents Volume 29 Number 3 Sep 2014 Foreword Reflection on the 55th Scientific Meeting of Japan Society of Ningen Dock Reiji Terasaka bakia aea aea 2 0 0 a a a a a a e a a a aeaa E200 0 ea a 5 Review Lifestyle related Diseases as an Oxidative related Disease Minoru Yamakado A P R a E ss a ayes B R E D E R E RA ies 5 a a se vay E a B EIE ENS 7 Original Articles 1 Efforts to Encourage Health Check up Examinees to Undergo Further Examinations and Their Results Madoka Takeuchi et al TELELA ELA E cte EE RR RAE dr E god d Ede ERR UE put Rr ua Eran dr TEETE A 13 2 Study on Improving Accuracy of Medical Interviews Yuki Rokuta et al Viscera cd arc WRI EE iS A tate a ois IS a odis CS ay en qo Sew el Wo ruo cV et Rar NC Sa KR CALCE en a gt Seis ial BE FOR den E 1
230. 2 B 1 1 1 3 2 4 9 3 10 4 C 1 1 1 2 D 0 1 10 2 10 49 3 50 99A4 100 5 E 1 2 3 F 1 2 3 G 9 1 10 4942 50 9943 100 4 H 2 1 3 5 2 6 943 10 19 4 20 5 1 1 2 3 Rl 131 509 4 R 20 57 30 219 40 156 50 148 60 60 m 4 254 347 5 17 13 m 174 298 3 162 2 1 591 49 1 52 1 3 136 4 9 287 10 165 1 265 1 375 0 94 10 186 10 49A215 50 99A70 100 65 10 517 10
231. 3 OR 27 61 8 21 22 28 62 8 20 21 29 63 8 25 26 30 1 8 24 25 31 2 8 23 24 HE E pe 32 3 8 22 23 hese eae 33 4 9 3 4 W lies Alan dS A 34 5 8 26 27 hinds 35 6 10 20 21 EFR eae 36 7 8 24 25 37 8 8 29 30 38 9 8 21 22 IK 68 526 Vol 29 No 3 201446
232. 6 64 313 319 Spergel JM Andrews T Brown Whitehorn TE et al Treatment of eosinophilic esophagitis with specific food elimination diet directed by a combination of skin prick and patch tests Ann Allergy Asthma Immunol 2005 95 336 343 Remedios M Campbell C Jones DM et al Eosinophilic esophagitis in adults clinical endoscopic histologic findings and response to treatment with fluticasone propionate Gastrointest Endosc 2006 63 3 12 20 Straumann A Conus S Degen L et al Budesonide is effective in adolescent and adult patients with active eosinophilic esophagitis Gastroenterology 2010 139 1526 1537 21 Ngo P Furuta GT Antonioli DA et al Eosinophils in the esophagus peptic or allergic eosinophilic esophagitis 14 15 16 ue 18 lt gt 19 49 507 Case series of three patients with esophageal eosinophilia Am J Gastroenterol 2006 101 1666 1670 22 Dellon ES Aderoju A Woosley JT et al Variability 24 in diagnostic criteria for eosinophilic esophagitis a systematic review Am J Gastroenterol 2007 102 2300 2313 23 Foroutan M Norouzi A Molaei M et al Eosinophilic Yoshiaki Kita Makoto Tatewaki Maiko Furukawa Mariko Yanai Ryo Hashimoto Junko Sano 50 508 reflux disease Dig Dis Sci 2010 55 28 31 2003 125 1660 1669 2014 6 2 Six Cases of Eosinophilic Esophagitis Ikum
233. 65 0083 i http convention jtbcom co jp b6jsnd 800 10 E 2015 1 15 2015 3 23 1 i 4 B
234. 9 3 Association between H pylori infection and Dental Disease Yoshiko Mizuno et al NENNEN gruesa ie EAEE BER UV eun RR I bust oh d ie e nee BPS BS a RC puntas e oe 0 EAEEREN 26 4 Pathological Significance of Trace Protein Reading in Urinalysis by Dipsticks Kazunari Banba et al eat AR catena rie sea ah Bee a ra rie epe as Be cre weal deri wie e ah Row c RE arie cce e as B c ne oa rie ee eat De ina Be 32 5 Analysis of Determining Factors in Motivating Follow up Subjects to Undergo Further Examinations Maki Hamanosono et al BENS Be erige race ar wo ROe a rdi KFE EC Na RI RIA Ta Sh ere eer sr ere 38 Case Report Six Cases of Eosinophilic Esophagitis Yoshiaki Kita et al D EE RUE ERA E ETIN REP NS E EET ERI E 45 Report Agenda of the Leaders and Institution and Leader Upbringing Business in the Specific Health Instruction Takashi Wada et al rmm 5 Notifications Committee Reports ee so PUR PTP TI n NE Bie e ee FE Je RN RU RIP Bebe ad winds S RR RU INC RI UR DTP PT ey ay BL ere IF RU UR BURN let ieee vee ay awe 57 Records of Recent and Past Scientific Congresses 1 cp Reis ao DR arial Brie eaten aha Gr er ene rie e rr ah IU e ra SAL 68 Instructions to Authors rr EE TSC FYTTE FFP 70 Note weh hh hh hh hh hh hh hh hh hh hh hh hh hh hh hh hh hh hh hh hh ttn 98 55 55
235. I Kg m 23 1 3 3 23 9 3 0 21 7 3 1 0 0001 LDL HDL 2 12 0 75 2 26 0 76 1 91 0 67 0 0001 TG mg dL 117 87 134 101 88 41 lt 0 0001 y GTP U L 44 9 56 3 56 0 66 8 26 1 21 4 lt 0 0001 SBP mmHg 126 19 129 19 12119 lt 0 0001 DBP mmHg 79 12 81 11 7511 lt 0 0001 max IMT mm 1 69 0 90 1 82 0 90 1 48 0 66 lt 0 0001 FPG mg dL 101 18 104 19 95 14 lt 0 0001 HbA 1 c 96 5 44 0 59 5 48 0 66 5 37 0 46 NS HOMA R 1 62 1 61 1 75 1 41 1 39 1 88 0 0001 hs CRP mg dL 0 106 0 358 0 113 0 359 0 092 0 355 0 0001 4 B R 3 A B C n 166 n 375 n 219 dia 62 6 10 3 62 3 9 8 63 5 9 7 NS BMI kg m 24 0 2 6 24 3 3 1 24 6 3 1 NS SBP mmHg 131419 133 18 134 20 NS DBP mmHg 82 11 83 11 84 12 NS ALB mg dL 4 50 0 23 4 51 0 25 4 45 0 28 NS TBIL mg dL 0 95 0 34 0 94 0 31 0 89 0 38 0 0139 UA mg dL 6 36 1 16 6 26 1 29 6 37 1 24 NS TC mg dL 201 27 208 31 213 44 0 0047 TG mg dL 125 79 123 69 179 231 0 0015 HDL C mg dL 61 3 15 4 60 2 15 6 55 3 13 7 lt 0 0001 d ROMs TG HbA1c UA CRP LDL HDL HOMA IR UA CRP UA CRP BAP
236. ISSN 1880 1021 Official Journal of Japan Society of Ningen Dock t NN 2014 9 Vol 29 No Ningen Dock International 1 1 2 25 ASN A a 9 5 55 25 284 1 3 4 55 Ningen Dock International Vol 1 No 1 38 9 BB M 1
237. No 3 2014 26 6 19 a ae e S 7 K A T jon 1f 7 2 IL E AY t wel Vol 29 No 3 2014 63 521 26 1 H 26 6 19 A 16 30 17 00 NE 3 A A CELO REZE MR PEE E SE fA 29 Wr HA Bade k V ERR 45 30 26
238. Slc BAT iX EHI AIL 25 12 AT Be X134 LAL 1 7 1mg dL i BEATA
239. Yamakado M Toda A et al Relationship between estimated glomerular filtration rate albuminuria and oxidant status in the Japanese population BMC Nephrol 2013 14 191 Fukui T Yamauchi K Maruyama M et al Significance of measuring oxidative stress in lifestyle related diseases from the viewpoint of correlation between d ROMs and BAP in Japanese subjects Hypertens Res 2011 34 1041 1045 Ishizaka N Ishizaka Y Takahashi E et al High serum bilirubin level is inversely associated with the presence of carotid plaque Stroke 2001 32 580 583 13 Tanaka M Budhathoki S Hirata A et al Behavioral and clinical correlates of serum bilirubin concentrations in Japanese men and women BMC Endocr Disord 2013 13 39 Ishizaka Y Yamakado M Toda A et al Relationship between coffee consumption oxidant status and antioxidant potential in the Japanese general population Clin Chem Lab Med 2013 51 1951 1959 15 Leufkens AM van Duijnhoven FJ Woudt SH et al Biomarkers of oxidative stress and risk of developing colorectal cancer a cohort nested case control study in the European Prospective Investigation Into Cancer and Nutrition Am J Epidemiol 2012 175 653 663 16 Suzuki Y Imai K Takai K et al Hepatocellular carcinoma patients with increased oxidative stress levels are prone to recurrence after curative treatment a prospective case series study using the d ROM test J Cancer Res Clin Oncol 2013 139 845 852
240. abic numerals A brief descriptive legend should be provided for each figure Legends are part of the text and should be appended to it on a separate page Color figures can be reproduces if necessary but the authors will be expected to contribute towards the cost of publication Conflict of Interest COI All authors are required to disclose any conflict of interest COI on the form designated by the Japan Society of Ningen Dock If no author has any COI this should be indicated in the manuscript Page proofs The corresponding author will receive PDF proofs the author should correct only typesetting errors After correcting page proofs must be returned promptly Reprints Thirty reprints of each paper are free and additional reprints are available at charge in lots of 10 but for a minimum order of 50 Reprints should be ordered on submission of the manuscript as follows For example I order 100 reprints 30 free 70 The Editorial Board considers only manuscripts prepared according to the Instructions to Authors and makes decisions regarding the acceptance of manuscripts as well as the order of printing them All published manuscripts become the permanent property of Japan Society of Ningen Dock and may not be published elsewhere without written permission from the Society 88 546 Vol 29 No 3 2014 Check list for submission of papers to Ningen Dock International Official Journal of Japan Society o
241. and diastolic blood pressure electrocardiographic findings and serum uric acid level were examined Results The cross sectional and longitudinal examinations revealed that the rate of abnormal findings for the examined items was higher in the trace proteinuria positive group than in the negative group Conclusion The rates of abnormal findings for renal and cardiovascular functions and also uric acid levels were higher in the trace proteinuria positive group than in the negative group Therefore a trace protein reading in urinalysis by dipsticks was concluded to have pathological significance Keywords urinary protein renal and cardiovascular functions CKD Vol 29 No 3 2014 37 495 m 29 496 502 2014 X E
242. are explained in footnotes Figures Figure legends are appended to the text on a separate page The top of the figure the first author s name and the figure number are indicated lightly in soft pencil on the back of the four figures Submission Check list agreement cover letter manuscript title page abstract text acknowledgments and references figure legends tables figures and or photos prepared in due form One set of the original manuscript and three sets of the copies with original photos if any are submitted All pages are numbered Date Name print Signature Vol 29 No 3 2014 91 549 ke HX Official Journal of Japan Society of Ningen Dock s Agreement 1 The authors undersigned hereby affirm that the manuscript entitled is original and does not infringe any copyright and that it has not been published in whole or in part and is not being submitted or considered for publication in whole or in part elsewhere except in the form of an abstract 2 Assignment of Copyright The authors hereby transfer assign or otherwise convey all copyright ownership to Japan Society of Ningen Dock in the event this work is published by Japan Society of Ningen Dock in any format 3 Signature of all authors Name print Name print Name print Name print Name print Name print Name p
243. chi Yasuhiro Ogata Japanese Red Cross Society Kumamoto Health Care Center Abstract Objective At our center in order to ensure safety in examinations the treatment sta tus of examinees is checked by collecting information beforehand as well as in medical interviews on the day of examinations for those deemed to be at high risk a nursing record is generated and risk management conducted We carried out a study to enhance the accuracy of medical interviews by assessing the current situations of examinees Methods From among 25 352 persons who underwent a one day Ningen Dock be tween April 1 2012 and March 31 2013 we extracted those at high risk and conducted an investigation to determine the numbers of those for whom a nursing record was gen erated and those in whom an exam had been cancelled as well as the numbers of inci dents that occurred We also investigated the times taken for information collection and medical interviews Results Among the 25 352 persons who underwent the 1 day Ningen Dock 4 772 had a history of high risk conditions There were 4 697 with hypertension nothing was done about 136 129 with unruptured aneurysms 86 not operated on and 64 with thoraco abdominal aneurysms 48 not operated on The number of nursing records generated was 258 for hypertension Ningen Dock cancelled for 13 certain exams cancelled for 79 exams performed at a later date for 15 exams continued with completion of consent form for 151
244. claration of Helsinki of 1964 subsequent revisions included Therefore for a manuscript whose content is epidemiological or clinical research the approval of the facility s Institutional Review Board IRB or the Ethics Committee of Japanese Society of Ningen Dock must have been obtained for the study described Also in the text it should be indicated that informed consent has been obtained from subjects Additionally for case reports it should be stated that adequate care has been taken to ensure the privacy of the subject concerned Online submission system Ningen Dock uses an online submission system called ScholoarOne Manuscripts Please access http mc manuscriptcentral com ningendock This site is only in Japanese at this time Preparation of manuscript All manuscripts must be written in English with MS Word Excel PowerPoint and or a common graphic format Authors who are not fluent in English must seek the assistance of a colleague who is a native English speaker and is familiar with the field of the manuscript The title abstract text acknowledgments references tables and figure legends should begin on separate sheets with pages numbered and be typed double spaced using the 12 point font size in MS Word Files for submission should be prepared in English in a Microsoft Word or other file format that may be uploaded to the online system Available formats for files to be uploaded doc docx xls xlsx ppt pptx jpg tif
245. ental caries periodontitis Methods The population of the study was 68 subjects 34 82 years old mean age 59 who had undergone esophagogastroduodenoscopy and blood tests Student s t test and the chi square test were applied Results In line with previous studies pepsinogen I II and anti helicobacter pylori anti gens IgG were low gastric disease 4 2 disease 5 8 p 0 023 and high gastric disease 42 2U mL disease 8 7U mL p 0 015 respectively in subjects with gas tric disease However subjects with dental caries periodontitis had a low prevalence of gastric disease Moreover the pepsinogen I II ratio was high p 0 012 and anti helico bacter pylori antigen levels were low 0 020 in subjects with periodontitis Similar results were seen in those with dental caries although they were not statistically signifi cant Conclusions There was not enough evidence for an association between H pylori infec tion and dental disease Further studies are needed to clarify whether there is a causative link between H pylori infection and dental disease in the Japanese population Keywords Helicobacter pylori dental caries periodontitis Vol 29 No 3 2014 31 489 29 490 495 2014 SE
246. f gif ai eps psd File names must consist of alphanumeric characters and an extension Example file names Manuscript doc Fig 1 jpg Table xls etc Please indicate the version of Microsoft Office used in a cover letter accompanying the uploaded files All measurements should be expressed in SI units Less common abbreviations should be spelled out at first usage and the abbreviated form used thereafter Title page Titles should be concise and informative Include the full names of authors names and addresses of affiliations and name and address of a corresponding author to whom proofs are to be sent including a fax number telephone number and e mail address Abstract The abstract should not exceed 250 words and should be arranged under the following subheadings Objective Methods Results Conclusions and have up to 4 keywords Types of articles Original articles An original article should not exceed 3 000 words and should be arranged as follows Abstract Objective Methods Results Discussion Conclusion Acknowledgments and References Vol 29 No 3 20144F 87 545 Case reports A case report should not exceed 2 000 words and be arranged as follows Abstract which should be a brief summary of the content without headings Introduction Case report Discussion and References Review articles Review articles should not exceed 4 000 words Review articles are usually by invitation However ar
247. f Ningen Dock Categories of manuscript Original article not more than 3 000 words Case report not more than 2 000 words Review article not more than 4 000 words Typing Manuscript on A4 paper with wide margins Type double space using 12 point Title page Title of paper Full names of authors and affiliations without title of MD PhD etc Full name and address of a corresponding author including fax number telephone number and e mail address Running title not more than 50 characters Abstract Not more than 250 words Arranged in the order of Background Methods Results and Conclusion Up to four key words Text of paper Manuscript is arranged in the order of Objective Methods Results Discussion Conclusion Acknowledgments and References Measurements are expressed in SI units Abbreviations are spelled out at first usage References References are numbered consecutively in order of appearance in the text and cited in the text using superscript numbers Format is consistent with examples in Instructions for Authors Vol 29 No 3 2014 89 547 Z 7i Tables Each table is given a number and a brief informative title and appears on separate page All abbreviations used
248. i Genka Junichi Taguchi Toshiomi Kusano Minoru Yamakado Mitsuru Kaise 8 1 Tokyo Midtown Clinic and Health Screening Center 2 Department of Gastroenterology Toranomon Hospital Abstract Objective To investigate the clinicopathological features of 6 patients who were diag nosed as eosinophilic esophagitis EoE in our clinic Methods From October 2012 to February 2014 6 patients who were definitively di agnosed as EoE with endoscopic biopsies of the esophagus more than 20 eosinocytes HPF in our clinic were analyzed retrospectively Results All the patients were men with a median age of 38 5 range 25 47 years old Two patients visited our clinic complaining of dysphagia Four patients underwent en doscopy and were coincidentally diagnosed as EoE during a health check up Three of the 4 patients were asymptomatic while one had slight dysphagia Endoscopic examina tion revealed furrows and fixed rings in all patients while exudates were observed in 2 patients Three patients who had allergic disease allergy to buckwheat prawns and crustaceans were treated with dietary elimination One patient was treated with topical steroid therapy fluticasone In one patient who had dietary elimination therapy endo scopic and histopathologic findings disappeared after two months Conclusion When the patients without any symptoms during a health check up have endoscopic features such as furrows rings or exudates multiple eso
249. itis patients J Periodontol 2003 29 487 74 129 134 6 Gebara EC Pannuti C Faria CM et al Prevalence of Helicobacter pylori detected by polymerase chain reaction in the oral cavity of periodontitis patients Oral Microbiol Immunol 2004 19 277 280 7 Eskandari A Mahmoudpour A Abolfazli N et al Detection of Helicobacter pylori using PCR in dental plaque of patients with and without gastritis Med Oral Patol Oral Cir Bucal 2010 15 e28 31 8 Riggio MP Lennon A Identification by PCR of Helicobacter pylori in subgingival plaque of adult periodontitis patients J Med Microbiol 1999 48 317 322 9 Souto R Colombo AP Detection of Helicobacter pylori by polymerase chain reaction in the subgingival biofilm and saliva of non dyspeptic periodontal patients J Periodontol 2008 79 97 103 10 Socransky SS Haffajee AD Dental biofilms difficult therapeutic targets Periodontol 2000 28 12 55 11 Herrera D Alonso B Le n R et al Antimicrobial therapy in periodontitis the use of systemic antimicrobials against the subgingival biofilm J Clin Periodontol 2008 35 8 Suppl 45 66 12 G rb z AK Ozel AM Yazgan Y et al Oral colonization of Helicobacter pylori risk factors and response to eradication therapy South Med J 2003 96 244 247 13 Gebara EC Faria CM Pannuti C et al Persistence of Helicobacter pylori in the oral cavity after systemic eradication therapy J Clin Periodontol 2006 33 329 333 14 Zo
250. kemiya Y Iseki C et al Proteinuria and the risk of developing end stage renal disease Kidney Int 2003 63 1468 1474 Hillege HL Janssen WM Bak AA et al Microalbuminuria is common also in a nondiabetic nonhypertensive population and an independent indicator of cardiovascular risk factors and cardiovascular morbidity J Intern Med 2001 249 519 526 Gerstein HC Mann JE Yi Q et al Albuminuria and risk of cardiovascular events death and heart failure in diabetic and nondiabetic individuals JAMA 2001 286 421 426 2014 1 16 17 18 2014 7 9 Pathological Significance of Trace Protein Reading in Urinalysis by Dipsticks Kazunari Banba Kentaro Shibuki Fujio Shimizu Yuki Kamimura Katsuyuki Kikuchi Mayumi Kasai Yoshiyuki Ohno Masaaki Fukuda Keiko Matsuura Minoru Murayama The Niigata Health Care Association Abstract Objective The aim of this study was to clarify the pathological significance of a trace protein reading in urinalysis by dipsticks Methods The rate of abnormal findings in renal and cardiovascular functions was cross sectionally compared at each year and longitudinally compared at 6 year intervals between groups divided by the degree of urinary protein reading in 222 255 specimens examined for 7 years from 2005 to 2011 at The Niigata Health Care Association Serum creatinine level estimated glomerular filtration rate systolic
251. l growth factor receptor tyrosine kinase inhibitor a 1 2 b 1 5 c 2 3 d 3 4 e 4 5 12 1 a b c d e ivedo reticularis GAIRE RE 13 HbA1c 75g OGTT 1 a 105 mg dL HbAlc 6 0 b 98 mg dL HbA1c 5 8 c 104 mg dL HbAlc 4 9 d LHE 288 mg dL HbA1c 6 3 1 e 96 mg dL HbA1c 6 5 14 1 2 CC 3
252. n data other release 2013 hantei_25 pdf 2013 12 16 2 REISS S74 Fy z x 2 EN v Z X f 96 97 http www mhlw go jp seisakunitsuite bunya kenkou iryou kenkou seikatsu dl hoken program2_07 pdf 2013 12 16 3 2009 http www niph go jp soshiki koku kk sosyaku opinion 1 doc_niigatamanual pdf 2013 12 16 4 CKD 2012 2012 25 28 5 http wwwrinfo pmda go jp tgo pack 21600AMZ00655000_ A_02_01 21600AMZ00655000_A_02_01 view body 2013 12 16 6 P C A C 2013 36 669 678 Vol 29 No 3 2014 7 Selvin E Juraschek SP Eckfeld
253. phageal mucosal biopsies should be obtained for diagnosis of EoE Keywords eosinophilic esophagitis EoE allergic disease dysphagia clinical guideline Vol 29 No 3 2014 esophagitis in patients with refractory gastroesophageal Straumann A Spichtin HP Grize L et al Natural history of primary eosinophilic esophagitis a follow up of 30 adult patients for up to 11 5 years Gastroenterology 2014 7 10 2 29 509 514 2014 g 25 C 2013 ARRE
254. qal R et al Effect of periodontal therapy on prevention of gastric Helicobacter pylori recurrence a systematic review and meta analysis J Clin Periodontol 2012 39 1166 1173 23 Elkind MS Infectious burden a new risk factor and treatment target for atherosclerosis Infect Disord Drug Targets 2010 10 84 90 2014 3 16 2014 6 17 30 488 Vol 29 No 3 2014 Association between H pylori infection and Dental Disease Yoshiko Mizuno Tsutomu Yamazaki Daisuke Koide Mikio Takanashi Issei Komuro 1 Department of Clinical Epidemiology amp Systems The University of Tokyo 2 Department of Cardiovascular Medicine The University of Tokyo 3 Clinical Research Support Center CresCent The University of Tokyo Hospital Abstract Objective Helicobacter pylori H pylori are gram negative microaerophilic spiral shaped bacteria found in the gastric mucosa Infection with this organism is connected with peptic and duodenal ulcers gastric carcinoma and non Hodgkin s lymphomas of gastric mucosa associated lymphoid tissue MALT On average 5096 of people in the world are infected by this microorganism The route by which H pylori infection is transmitted is not yet clear and there are many unanswered questions among them whether the oral cavity could be considered as a reservoir of these bacteria We investi gated a relationship between H pylori infection and d
255. rint Signature Signature Signature Signature Signature Signature Signature Date A Date A Date A Date A Date A Date A Date A A Vol 29 No 3 2014 93 551 zh H Be An Fs 1 1 5 AG 1 5 anhydroglucitol 1 5 2 17 OHCS 17a hydroxycorticosteroid 17 3 95 CI 95 confidence interval 95 4 a Gl a glucosidase inhibitor a 5 B MG PB microglobulin B 6 y GTP Y glutamyl transpeptidase 7 A G A G ratio albumin globulin ratio 8 ABI ankle brachial index 9 ACTH adrenocorticotropic hormone
256. sponses according to 5 grades Follow up subjects undergoing further examinations were divided into a cancer examinations related group A group and an others lifestyle related disease examinations related group B group and analyzed according to the Ajzen theory of planned behavior Results In the analysis of background factors of follow up subjects having and not having further examinations there were significant differences in examination behavior undergo or not undergo further examinations regarding age and married unmarried status p lt 0 05 In the analysis of the results of the questionnaire survey according to planned behavior theory factors encouraging positive examination behavior identified for the A group were Results report Examinee awareness Recommendation by other person and System of institution performing further examinations Conclusion Based on the above findings we considered that important actions required to further increase further examination rates were more thorough explanation of results by doctors more detailed selection of institutions for further examinations in consideration of examinee convenience provision of appointment systems and investigation of examinee workplace situations Keywords encouragement to undergo further examinations further examination rate follow up 44 502 Vol 29 No 3 20144F 29 503 508 2014
257. t J et al Within person variability in kidney measures Am J Kidney Dis 2013 61 716 722 8 CKD 2008 97 1108 1116 9 http www e kenkou21 or jp guidance guidance02 guidance02_set02 guidance02_04 2013 12 16 10 SES 1994 42 1067 1071 11 2005 94 354 12 jE EFEN po 2007 22 592 600 13 Nagata M Ninomiya T Kiyohara Y et al Prediction of cardiovascular disease mortality by proteinuria and reduced kidney function pooled analysis of 39 000 individuals from 7 cohort studies in Japan Am J Epidemiol 2013 178 1 11 14 Konta T Hao Z Takasaki S et al Clinical utility of trace proteinuria for microalbuminuria screening in the general population Clin Exp Nephrol 2007 11 51 55 15 Sam R Shaykh MS Pegoraro AA et al The significance of trace proteinuria Am J Nephrol 2003 23 438 441 16 Iseki K I
258. ticles submitted without an invitation may also be considered by the Editorial Board References References should be numbered consecutively in order of appearance in the text and cited in the text using superscript numbers For example according to the study by Sasamori For journals the names and initials of the first three authors followed by et al if there are other coauthors the complete title abbreviated journal name according to Index Medicus volume beginning and end pages and year should be included For books the names and initials of the first three authors followed by et al if there are other coauthors the complete title book name edition number beginning and end pages name and city of publisher and year should be included Examples of references are given below Journal Ishizaka N Ishizaka Y Nagai R et al Association between white cell count and carotid arteriosclerosis in Japanese smokers Atherosclerosis 2004 175 95 100 Book Kaplan NM Measurement of blood pressure In Kaplan NM ed Kaplan s Clinical Hypertension 7th ed Lippincott William amp Wilkins Philadelphia 2002 25 55 Tables Tables should be cited in the text and numbered sequentially with Arabic numerals Each table should be given a number and a brief informative title and should appear on a separate page Explain in footnotes all abbreviations used Figures Figures should be cited in the text and numbered sequentially with Ar
259. u QH Li RQ Helicobacter pylori in the oral cavity and gastric mucosa a meta analysis J Oral Pathol Med 2011 40 317 324 15 Miyabayashi H Furihata K Shimizu T et al Influence wm lI a of oral Helicobacter pylori on the success of eradication therapy against gastric Helicobacter pylori Helicobacter 2000 5 30 37 Oishi Y Kiyohara Y Kubo M et al The serum pepsinogen test as a predictor of gastric cancer the Hisayama study Am J Epidemiol 2006 163 629 637 Gunji T Matsuhashi N Sato H et al Helicobacter pylori infection is significantly associated with metabolic syndrome in the Japanese population Am J Gastroenterol 2008 103 3005 3010 Gunji T Matsuhashi N Sato H et al Helicobacter pylori infection significantly increases insulin resistance in the asymptomatic Japanese population Helicobacter 2009 14 144 150 Corrado E Rizzo M Tantillo R et al Markers of inflammation and infection influence the outcome of patients with baseline asymptomatic carotid lesions a 5 year follow up study Stroke 2006 37 482 486 Mayr M Kiechl S Mendall MA et al Increased risk of atherosclerosis is confined to CagA positive Helicobacter pylori strains prospective results from the Bruneck study Stroke 2003 34 610 615 21 Poppe M Feller SM R mer G et al Phosphorylation of Helicobacter pylori CagA by c Abl leads to cell motility Oncogene 2007 26 3462 3472 22 Bouziane A Ahid S Abou
260. up Results We compared the further examination rates for each year beginning in 2010 In 2010 and 2011 the rates increased for all examinations Comparing 2011 with 2009 the increase in the stomach X ray examination rate in 2012 was 30 9 the biggest in crease Next came fecal occult blood chest X ray cervical cytology breast cancer and gastroscopy examinations in that order with increases of 27 6 24 2 16 0 14 7 and 10 8 respectively Conclusion Our findings suggested that encouragement from doctors and public health nurses and the provision of information on medical institutions on the day of the health check up could motivate examinees to undergo further examinations Also issuing re ferral letters and conducting follow up investigations were effective in increasing the rate of knowing the further examination status as well as the percentage of examinees undergoing further examinations Future issues to be addressed are raising the effective ness of interviews with public health nurses and improving response rates for question naires used in follow up investigations Keywords further examinations further examination rate encouragement to undergo further examinations follow up investigation 18 476 Vol 29 No 3 2014 29 477 483 2014 eH CEST
Download Pdf Manuals
Related Search